Search

everythinglearnresearchcommunity

for

Search:↓

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Consider benefits and risks of new alopecia treatments for safety.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Hair growth environment recreated with challenges; stem cells make successful skin organoids.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Superficial cryotherapy significantly improves eyebrow hair growth in alopecia universalis patients.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

Stephen Rothman made important discoveries in dermatology, including the use of PABA in sunscreens, but never profited from his work.